revenu growth rebound prime invest
weigh near-term margin maintain outperform
exce metric increas buy-back valuat remain
takeaway strong print maintain outperform
strong increas guidanc product traction
continu provid book momentum
improv optun reimburs
physician weigh allogen car-t result prescrib
color fundament focu call
taz get prioriti review es nda fl track
record enterpris deal pipelin increas mix creat
uncertainti time book lumpi
consider ahead result
report strong wait
analyst certif import disclosur see
execut accord strateg solid quarter
enhanc product
first look strong subscrib growth help churn
sp commerc report solid analyt back
invest optim cloud
carbonit disappoint result reset growth
ota deliv global share gain pt
look lever mitig pressur lower pt
first look result
manag uncertain macro
price disciplin offer plenti posit
trim estim follow pre-announc price
guidanc cut miss provis off-set
result show power busi model
revenu growth rebound prime invest weigh near-term margin maintain outperform
maintain price target outperform rate revenu modestli exceed street estim
e-commerce re-acceler prime off-set lower aw revenu meanwhil prime cost higher initi
management expect aw market hardwar video invest caus ebit miss aw revenu deceler
y/i y/i management blame tough custom usag comp suggest re-acceler futur quarter
combin higher opex aw ebit street estim advertis acceler wfm growth stabl
guidanc impli revenu y/i vs lower margin prime roll-out cost given
success make invest expect investor look near-term margin pressur
exce metric increas buy-back valuat remain
maintain outperform rate rais price target result exceed
metric compani increas repurchas author modest acceler gross websit stabil
net websit revenu stabl net allay fear secular slowdown vs time product releas youtub
second-biggest driver growth mobil search follow cloud run-rat total net revenu acceler
y/i vs googl segment ebitda increas y/i vs increas ebitda
ep respect ep aid repurchas
takeaway strong print maintain outperform
consist preview analysi provid uniqu beat-and-rais releas compstore flex
easiest comparison busi cycl global believ healthi trend sustain digit accret
improv cold beverag roll-out intensifi ubereat scale nation along respect outlook core
margin posit model solidli street ebit assumpt ep come higher tax
rate issu investor could nitpick limit oper profit flow-through compstore beat two-year traffic
trend remain flat
sold print recent soft juli industry-wid sale data telegraph temper start
rel sell-sid estim take advantag pull-back reiter outperform rate establish
june updat estim share current trade ebitda steady-st yield
put compani play legitim take-out candid comp flattish first week
see path compstore acceler multipl expand expect street ebitda estim move
lower print disast investor alreadi price valuat
strong increas guidanc product traction continu provid book momentum
beat expect comfort move rev/ep guidanc midpoint higher compani also lift
book midpoint cite strong momentum core xt newer product launch past sever
quarter strateg platform combin sever product autonom pharmaci concept gain traction
sever partnership quarter management note backlog all-tim high grow faster revenu
contract involv multipl product continu impress us believ import rx management insid outsid
hospit increas continu exhibit well differenti product reiter outperform target
improv optun reimburs
announc revenu higher consensu estim driven improv reimburs
us one-tim benefit collect manag indic reimburs improv sustain howev
collect benefit futur period may margin compani achiev sever key mileston quarter
import view favor medicar reimburs rate first-lin gbm maintain outperform rate
revis price target vs primarili owe higher revenu futur period improv gross margin
year-end anticip updat optun launch time china mileston trigger event also continu expect
medicar reimburs histor claim note time amount payment remain uncertain
physician weigh allogen car-t result prescrib survey
today commerci avail chimer antigen receptor cell car-t therapi offer lifelin heavili pretreat patient
suffer certain hematolog malign conduct blind physician survey ascertain prescrib
percept surround limit current approv car-t product therapeut potenti off-the-shelf
allogen altern nearli respond believ allogen car-t could overcom key limit autolog
car-t envis car-t deploy second third-lin set importantli prescrib indic
may will exchang perform efficaci safeti conveni consist could
deliv off-the-shelf product survey data reinforc confid allogen product could eventu
becom standard care certain aggress leukemia lymphoma myeloma believ result posit
ramif sever allogen car-t develop includ cll crsp amongst sever
color fundament focu call
taz get prioriti review es nda fl track
tazemetostat nda epitheloid sarcoma indic grant six-month prioriti review januari
fda action date assign expect acceler approv on/around time given robust data rare
malign lack approv option taz develop much larger follicular lymphoma market opportun
continu progress second nda submiss r/r fl remain schedul believ share
outperform tazemetostat progress develop approach commerci earlier
record enterpris deal pipelin increas mix creat uncertainti time book lumpi
vocera beat estim guidanc cut disappoint investor despit growth enterpris deal
pipelin management cut guidanc midpoint cite delay enterpris deal convers although
pick vendor choic increment approval/paperwork step fulli convert book take longer
sinc deal usual cover entir hospit instead one two depart believ process could
elong caus pipelin convers choppi uncertainti around book time unnerv
investor believ compani product competit posit record enterpris pipelin reiter
outperform rate adjust target
consider ahead result
highlight sever key topic ahead result updat jakafi script suggest volum growth
y/i without price increas lead us sale estim vs consensu note
jakafi sale guidanc long-term guidanc fda approv jakafi acut
steroid-refractori graft vs host diseas agvhd launch updat posit result topic ruxolitinib vitiligo
fda grant btd pemigatinib cholangiocarcinoma cca regulatori file expect may hear
potenti tumor-agnost develop refocu capit alloc oper new cfo
updat model adjust revenu ep detail full report
report strong wait
report adj ep vs opco/street estim adj-result exclud
normal item oig/stock options/stock comp/etc larg beat vs model driven combin segment
vita margin notabl out-performance bp vs estim due soon-to-be-releas highli
benefici medicar final rule announc would wait re-visit ep guidanc previous
exclud potenti materi benefit ep estim rais
furthermor rais price target
exceed estim across board up outlook acceler cloud migrat trend
strong cloud-bas revenu y/i coupl rapid adopt emerg product underscor
strong result despit emerg view recent improv secur solut email ident
would appear current landscap still govern view good enough enough benefit pure
play email specialist like displac legaci provid coupl savvi tuck-in provid support
revenu growth manag run year ahead margin target provid analyst
day pleas result maintain perform rate given recent run-up
execut accord strateg solid quarter enhanc product
report solid quarter revenu ebitda ep exceed guidanc outlook remaind
year up slightli revenu direct y/i mid-point encourag highlight
quarter includ solid execut track strateg plan revenu gener growth segment inflect
posit bp sequenti progress deliv strateg initi notic launch
gotoconnect bundl offer best featur jive gotomeet drive strong demand attach rate
track doubl compani growth rate driven product enhanc simpler try-and-buy
option overal anoth confirmatori step right direct
report mix result opinion y/i revenu declin organ math
exceed estim also adj ebitda beat estim reflect y/i margin
contract rais guidanc less anticip given recent mortgag market improv guid
reflect anticip wind-down transform certain busi anticip revenu
adj ebitda adj ep curious low
profit flow-through rel revenu guidanc increas revenu increas reflect combin mortgag
market benefit slower anticip low-margin revenu loss transform maintain outperform
attract yield
post solid result y/i organ revenu growth ep vs our/street
estim organ growth mix payment growth y/i respect affirm
outlook anticip organ revenu growth anticip ep exclud fdc merger impact
remain attract busi model lt prospect highli enthusiast immin pend
merger fdc gener signific revenue/cost synergi relat ep accret
next five year encouragingli manag anticip meaning financi impact fdc/bofa jv negoti
trade pro forma ep estim includ fdc share appear attract reiter outperform rate
cloud
first look strong subscrib growth help churn merger approv forthcom
total revenu miss street-high estim mostli lumpi equip revenu ebitda margin line
posit saw strong net add postpaid prepaid vs est churn
tick arpu miss estim bp manag rais guidanc adj ebitda
brand postpaid net add compani like gain flow
share postpon earn confer call wait doj negoti state approv
view merger posit wireless industri particularli lt valuat cable/tow would like trade
model updat previous aggress margin front still bullish long-term margin expans
sp commerc report solid analyt back convers reiter outperform
report solid result street estim rais guidanc highlight includ
anoth quarter good consist execut expand ebitda margin strong gener addit
compani larg analyt deal suggest end-market stabil demonstr scalabl
increas referenc posit balanc ebitda guidanc impli margin expans trend
may slower busi display bottom line deliv anoth consistent-execut
quarter amid evolv retail end-market good news improv visibl long-term ebitda margin
target continu futur quarterli result support valuat
junip report solid result return growth cloud secur off-set soft enterpris servic
provid vertic manag tone upbeat guidanc mostli posit qoq revenu growth om
expans ep guid bottom end rang reflect tariff higher tax posit junip
sale reorgan expect new hire ramp right junip begin ship refresh product
mx line-card qfx/ptx new mist wlan campu posit earli execut signal improv
pipelin visibl multipl product catalyst bearish investor sentiment see favor risk/reward scenario
maintain outperform price target
analyt collabor infrastructur softwar
invest optim cloud
atlassian report anoth strong quarter upsid revenu margin ep guidanc line
expect emb slight margin moder cloud mix on-going invest growth rate
headwind plan addit free entry-level edit cloud product free cloud trial on-premis
custom posit addit see seed continu new custom growth long-term user/
product expans effort also complement atlassian earlier addit premium cloud price tier jira confluenc
overal remain bullish see long runway growth new user new market new product opsgeni jira align
access trello price acv expans etc grow larg enterpris traction atlassian increas focu enabl
report sales/ep street estim provid guidanc ahead
consensu manag rais sales/ep impli weaker
given beat gm q/q though full year target unchang gm
expect flat cost ramp benefit sell written-off inventori fade
sale flag smartphon baseband busi remov eps/cf drag prove accret
cost save re-direct pull invest buffer core ccg/dcg share loss structur
growth capit alloc effect theme within semiconductor group see better exampl
elsewher maintain perform rate
everspin phison partner bring stt-mram control digitim
carbonit disappoint result reset growth expect maintain perform
consist downgrad report growth fear busi unabl expand suffici upmarket
transit legaci instal base cloud fast enough without fall weight roll-up strategi get
drag soften premise-bas sale unfortun gap busi fundament sell-sid
sentiment becam wide ever look set narrow manag took bath quarter posit
manag acknowledg concern reset expect declining-to-d minimu top-lin organ growth
trajectori bottom line despit after-hour sell-off elliott stock see carb share
upsid potenti rival rest saas/appl coverag univers given challeng
ota deliv global share gain pt
increas pt follow solid driven acceler ota trend offset
deceler vrbo book manag increas lower-end ebitda guidanc
trivago tailwind improv overhead cost leverag main pushback vrbo book deceler
seo headwind competit like play larg role howev ota market larger
suppli base creat sustain top-lin growth allow compani work unifi vrbo brand seo
addit optim vrbo transact fee still lower competitor provid healthier segment revenu growth
pt impli share trade ebitda line forward-year averag maintain outperform
report ep line estim penni consensu estim rel model sale
modestli light across segment strong fmt margin along lower corpor expens offset
top-lin miss exhibit
despit flat order trend uncertain macro environ manag remain confid sustain organ growth
margin expans balanc year organ sale guidanc revis
solid ytd oper perform continu execut rais low end ep guid cent vs
result line slight om/ep upsid core outlook trim slightli industri
short cycl busi measur analyt solut segment overal organ outlook
vs prior process organ expect upstream soft well flagged/plan
allow focu cash margin pt op flat y-o-i om bp within soft emerg
broadli across industri busi rel narrow within sweep rapidli june bounc back
juli project hsd vs msd overal organ outlook anticip organ two softwar
segment continu track solidli msd organ trend-line
sustain growth resourc optim
look lever mitig pressur lower pt
share trade thursday report in-lin ep lower outlook greater china
weak exacerb suppli chain cost pressur manag intend pull intern lever margin expans
provid concret detail quarter could posit catalyst anticip
restructuring/optim would unlik materi benefit take conserv view trim
organ growth margin estim respect accordingli take pt
believ nimbl execut key support out-performance share current level remain bullish
bwa posit benefit evolv propuls architectur requir
sustain growth resourc optim
first look result
re-affirmed adj guidanc increment commod price soft drove adj ebitda
consensu estim reduct fy adj ebitda guidanc weak energi metal price
incorpor estim revis translat increment ebitda headwind bridg maintain
guidanc appear work capit intern lever posit strong wast dispos price
guidanc provid cushion manag made chang fy outlook plant product
mainten moreov believ make solid progress key strateg growth initi includ uk wte
pipelin tap look increment color earn call tomorrow
sustain growth resourc optim
manag uncertain macro
share flattish thursday lower organ growth ep guidanc midpoint
respect modest decrement view reflect rok abil flex cost disciplin manag market
soft also view posit rok continu invest growth recur software/servic revenu
could focu novemb investor day said believ investor remain larg focus risk medium-
term organ growth amid macro uncertainti manag well describ trim organ growth
estim bp view deceler global growth remain sidelin
sustain growth resourc optim
price disciplin offer plenti posit
beat adj ep consensu gener margin expans reaffirm adj eps/fcf
guidanc averag yield ran ahead oper cost inflat restrict portion busi achiev
price growth reflect transit cpi altern increment margin includ labor mainten gain
offset recycl headwind outlook decade-high spend focus leverag core compet
wast materi manag provid top-line growth tailwind adjust forward estim capit
alloc thesi rate remain intact
sustain growth resourc optim
share modestli thursday wm beat ep consensu above-market organ growth solid wast
better oper leverag reaffirm adj ebitda/eps/fcf guidanc though manag character
current macro enigma earn call back-half volum comp challeng indic
special wast pipelin commerci servic level continu look broadli healthi view compani grow use
technolog tool drive top-line posit pend complet merger track manag voic appetit
tuck-in activ view current leverag manag thesi rate remain intact
trim estim follow pre-announc price deriv settlement
open thursday pioneer releas inform regard price realiz deriv activ third
parti purchas sale oil natur ga compani report mix price realiz oil come
expect natur ga ngl come well estim third parti purchas sale oil natur
ga well deriv activ came margin estim adjust model assumpt trim
estim model assumpt unchang
ep y/i consist consensu landstar origin guidanc
compani indic may achiev bottom end guidanc total revenue/
per load price declin y/i vs origin guidanc high-singl digit decreas industry-wid truck capac
readili avail number load via truck revenu per load total revenu adjust ep guid
low-singl digit low-doubl digit y/i respect adjust ep
modifi reduc revenu outlook
adjust ebitda y/i margin y/i match estim exceed
consensu consolid rental revenu total revenu grew y/
respect primari segment storag solut revenu tank revenu grew rental
revenu exclud fx north america y/i respect importantli increment adjust
ebitda margin exceed compani object segment overal second
consecut quarter remain upbeat relat busi condit across segment reiter
potenti conserv adjust ebitda estim y/i respect well
outperform target
guidanc cut miss provis off-set better tax rate
report core ep vs our/consensu help better tax rate share like
pressur due provis come wors expect credit better expect
compani leav us bit puzzl given industri trend although decreas see
roe yoy ep growth show resili credit competit in-school/refi
origin improv profit stock could turn around said moder expect price-to-earnings multipl
expans combin lower ep pt move turn increment cautiou given
roe trend slow ep growth
result show power busi model
kkr report after-tax distribut earn de essenti line estim compani
previous disclos realiz carri invest incom net number difficult come
alway said earn gener least interest aspect privat equiti pe base asset manag
earn report said key earn fundament line slightli better expect shown
actual versu estim analysi exhibit base manag fee right line expect stronger
expect capit market fee help drive small beat fee relat earn fre made modest tweak
estim valuat target
